Tonymoly Co., Ltd (KRX:214420)
South Korea · Delayed Price · Currency is KRW 6,680.00
+430.00 (6.88%)
At close: Apr 8, 2026
Tonymoly Revenue
In the year 2025, Tonymoly had annual revenue of 220.27B KRW with 24.45% growth. Tonymoly had revenue of 52.56B in the quarter ending December 31, 2025, with 21.83% growth.
Revenue
220.27B
Revenue Growth
+24.45%
P/S Ratio
0.68
Revenue / Employee
1.93B
Employees
114
Market Cap
149.39B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 220.27B | 43.28B | 24.45% |
| Dec 31, 2024 | 177.00B | 25.90B | 17.14% |
| Dec 31, 2023 | 151.09B | 24.35B | 19.21% |
| Dec 31, 2022 | 126.75B | 12.10B | 10.55% |
| Dec 31, 2021 | 114.65B | 1.19B | 1.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Aekyung Industrial | 654.53B |
| Kolmar Holdings | 630.11B |
| KOLMAR BNH | 574.88B |
| VT Co., Ltd. | 437.18B |
| Able C&C | 242.00B |
| It'S Hanbul | 153.39B |
| Monalisa | 140.89B |
| NeoPharm CO., LTD. | 132.18B |